SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-12-331370
Filing Date
2012-08-02
Accepted
2012-08-02 14:06:38
Documents
2
Group Members
BAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.P.BAY CITY CAPITAL FUND V, L.P.BAY CITY CAPITAL MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d390939dsc13d.htm SC 13D 112409
2 JOINT FILING AGREEMENT d390939dex9971.htm EX-99.7.1 2233
  Complete submission text file 0001193125-12-331370.txt   116413
Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 415.676.3830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD. SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-745-7802
HYPERION THERAPEUTICS INC (Subject) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86934 | Film No.: 121002889
SIC: 2834 Pharmaceutical Preparations